Assaf Oron
Corporate Officer/Principal bei BIOMX INC.
Profil
Assaf Oron is currently the Chief Executive Officer & Director at Evofuel Ltd.
and the Chief Business Officer at BiomX, Inc. He previously served as the Chief Executive Officer at Chondrocyte Ltd., Senior Project Manager at POC Management Consulting, Executive VP-Corporate Development at Evogene Ltd., and Chief Business Officer at BiomX Ltd.
Mr. Oron received his undergraduate and graduate degrees from Tel-Aviv University.
Aktive Positionen von Assaf Oron
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOMX INC. | Corporate Officer/Principal | 28.10.2019 |
| Evofuel Ltd. | Chief Executive Officer | 01.01.2012 |
Ehemalige bekannte Positionen von Assaf Oron
| Unternehmen | Position | Ende |
|---|---|---|
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Corporate Officer/Principal | 01.10.2019 |
| EVOGENE LTD. | Corporate Officer/Principal | 01.01.2017 |
| Chondrocyte Ltd. | Chief Executive Officer | 01.01.2006 |
| POC Management Consulting | Corporate Officer/Principal | 01.01.2003 |
Ausbildung von Assaf Oron
| Tel-Aviv University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| EVOGENE LTD. | Health Technology |
| BIOMX INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
| POC Management Consulting | |
| Evofuel Ltd. | |
| Chondrocyte Ltd. | |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
